Rigel PharmaceuticalsRIGL
13F holders, Q2 2024 (June 30)10holders −107
3new positions
38sold out
$7.12avg. 13F price*
At the end of Q2 2024, 10 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, down 107 from Q1 2024. 3 opened new positions and 38 sold out. The largest holders were Barclays PLC ($87K), Avior Wealth Management, LLC ($1K) and IFP Advisors, Inc ($807).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $1K |
| Exits | 38 | $17.8M |
All 13F filers, Q1 2024 → Q2 2024: 556 shares bought and 12,177,832 shares sold, net −12,177,276 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Barclays PLC | 0.00% | Reduce -93.0% | 10,573 | $87K |
| Avior Wealth Management, LLC | 0.00% | Reduce -90.3% | 126 | $1K |
| IFP Advisors, Inc | 0.00% | No change | 1,000 | $807 |
| Blue Trust, Inc. | 0.00% | No change | 500 | $740 |
| EverSource Wealth Advisors, LLC | 0.00% | New | 63 | $667 |
| Mather Group, Llc. | 0.00% | New | 450 | $666 |
| Institutional & Family Asset Management, LLC | 0.00% | Reduce -90.0% | 10 | $82 |
| Hexagon Capital Partners LLC | 0.00% | Reduce -90.9% | 2 | $17 |
| Huntington National Bank | 0.00% | Reduce -99.8% | 1 | $1 |
| Cwm, LLC | 0.00% | New | 43 | $0 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.